NCT03364608 - Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

March 30, 2018

Study Completion Date

March 30, 2018

Conditions

Asthma

Interventions

DRUG

AS MDI 90 μg

AS MDI 90 μg (2 actuations of 45 μg/actuation)

DRUG

AS MDI 180 µg

AS MDI 180 μg (2 actuations of 90 μg/actuation)

OTHER

Placebo MDI

Placebo MDI (2 actuations)

DRUG

Proventil 90 μg

Proventil 90 μg (1 actuation of 90 μg/actuation)

DRUG

Proventil 180 μg

Proventil 180 μg (2 actuations of 90 μg/actuation)

Trial Locations (10)

Research Site, Raleigh

Research Site, Spartanburg

Research Site, Winter Park

Research Site, Cincinnati

Research Site, St Louis

Research Site, El Paso

Research Site, Rolling Hills Estates

Research Site, Stockton

Research Site, Medford

Research Site, North Dartmouth